Search Smart Spending:

Walgreens settles lawsuit

Posted Aug 04 2009, 02:53 PM by Karen Datko
Rating:

This post comes from Jon Hood at partner site ConsumerAffairs.com.

Pharmacy giant Walgreens has settled a class-action lawsuit involving a generic version of the popular cold pill Airborne, itself the target of a recent class action.

The lawsuit alleged that Walgreens made false and misleading statements about its product, cleverly named Wal-Born (at one time spelled Wal-Borne). Specifically, Walgreens claimed that Wal-Born could treat or prevent the common cold, a claim strongly disputed by the plaintiffs.

Walgreens, the nation's largest drugstore chain, denies any wrongdoing in the settlement.

Anyone who purchased Wal-Born between May 24, 2001, and March 31, 2009, is eligible to take part in the settlement, which offers a choice between up to three refunds of $4.99 each, or a free flu shot, purportedly valued at $25.

Consumers need not present a receipt or proof of purchase to be eligible to submit a claim. Consumers who believe they may be eligible should visit the Wal-Born settlement Web site. (The class does not include purchasers of Wal-Born hand sanitizer.)

The claims in the suit were strikingly similar to those in a suit that brand-name Airbone settled last year. In March 2008, Airborne agreed to pay $23.3 million to settle a suit alleging that the manufacturer wrongly claimed the medicine would prevent colds. In August, Airborne paid more than $6 million to the Federal Trade Commission to settle allegations that the company did not provide sufficient evidence to support its claims about the product's effectiveness.

Lydia Parnes, director of the FTC's Bureau of Consumer Protection, said at the time that Airborne would not "reduce the severity or duration of colds, or provide any tangible benefit for people who are exposed to germs in crowded places."

Airborne and its generic counterparts have long had their critics. At the time of the Airborne settlement, David Schardt of the Center for Science in the Public Interest called the product "basically an overpriced, run-of-the-mill vitamin pill that's been cleverly, but deceptively, marketed."

Although prevalent in some of the nation's largest retailers, including Rite Aid and Wal-Mart, Airborne has not been tested by the Food and Drug Administration. That's because of a loophole in the law that allows dietary supplements -- but not "drugs" -- to be manufactured without government testing before entering the market.

Manufacturers of dietary supplements still must have evidence to support any claims made on the product's packaging. And as it turns out, the only study that actually suggested that Airborne was effective just happened to be commissioned by Knight-McDowell labs -- the same company that manufactures Airborne.

Judging from its Web site, Walgreens has decided that selling Wal-Born isn't worth the headache after all. The page labeled "Wal-Born: Effervescent Health Fomula" now reads simply, "Product is no longer active."

Related reading at ConsumerAffairs.com:

Airborne Health to pay FTC for false claims

States step up pressure on Internet payday lenders

Consumer bankruptcy filings at highest level in nearly 4 years

Comments

 

The form asks how much was spent for the Wal-Born, but I can't remember.  I did purchase several of these items but it was a couple years ago before I read that the item was hogwash.  How much did it sell for?  I can't remember.

Walgreens recently sent a $25 coupon for "transfer prescriptions" obviously to get customers to again use Walgreens for their Rx. I had a Rx filled and presented the coupon. It was refused because it was a prescription and is excluded! Clearly Walgreens policy of misleading the public continues. I DO NOT TRUST WALGREENS WORD NOR DO I TRUST WALGREENS TO FILL MY Rx. Your readers should be warned.

Send a Comment

Comments must be directly related to the blog entry. Comments with offensive language will be deleted. Your e-mail address won't be displayed.

(please, no HTML tags. Web addresses will be hyperlinked):